ArticleScientific reports2017

MALDI mass spectrometry imaging of erlotinib administered in combination with bevacizumab in xenograft mice bearing B901L, EGFR-mutated NSCLC cells.

Masanobu Nishidate et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.